View as an RSS Feed
PRO articles cover stocks that fly under most investors' radar screens.
Did Tesaro Just Enter Yet Another Overcrowded Space?
- Tesaro traded considerably higher on Thursday after striking a collaboration with private biotech, AnaptysBio.
- Unfortunately, the news only enters Tesaro into a crowded space where it must compete with the industry's elite.
- Tesaro entering and developing products in a crowded space is not uncommon, which could prevent short-term gains.
- Furiex Pharma: What's The Best Plan Of Action?
- NeoStem - Great Reverse-Split Activity, But What's Next?